Sponsor:
Genentech, Inc.
Code:
NCT04302025
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alectinib
Entrectinib
Vemurafenib (Enrollment closed)
Cobimetinib (Enrollment closed)
Pralsetinib (Enrollment closed)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations